FGF10 protects against particulate matter-induced lung injury by inhibiting ferroptosis via Nrf2-dependent signaling

• DOI: 10.1016/j.intimp.2024.112165
• Publication Date: 2024-05-01T01:03:15Z
• Authors: Yao Qian; Qiangqiang Shi; Wanting Zhou; Baiqi He; Haibo Xu; Bin Liu; Wanqi Miao; Saverio Bellusci; Chengshui Chen; Nian Dong
• Keywords: Male; Amino Acid Transport System y+; NF-E2-Related Factor 2; Epithelial Cells; Lung Injury; Phospholipid Hydroperoxide Glutathione Peroxidase; Cell Line; Mice, Inbred C57BL; Mice; Oxidative Stress; Disease Models, Animal; Ferroptosis; Animals; Humans; Particulate Matter; Fibroblast Growth Factor 10; Signal Transduction

Particulate matter (PM) is considered the fundamental component of atmospheric pollutants and is associated with the pathogenesis of many respiratory diseases. Fibroblast growth factor 10 (FGF10) mediates mesenchymal-epithelial signaling and has been linked with the repair process of PM-induced lung injury (PMLI). However, the pathogenic mechanism of PMLI and the specific FGF10 protective mechanism against this injury are still undetermined. PM was administered in vivo into murine airways or in vitro to human bronchial epithelial cells (HBECs), and the inflammatory response and ferroptosis-related proteins SLC7A11 and GPX4 were assessed. The present research investigates the FGF10-mediated regulation of ferroptosis in PMLI mice models in vivo and HBECs in vitro. The results showed that FGF10 pretreatment reduced PM-mediated oxidative damage and ferroptosis in vivo and in vitro. Furthermore, FGF10 pretreatment led to reduced oxidative stress, decreased secretion of inflammatory mediators, and activation of the Nrf2-dependent antioxidant signaling. Additionally, silencing of Nrf2 using siRNA in the context of FGF10 treatment attenuated the effect on ferroptosis. Altogether, both in vivo and in vitro assessments confirmed that FGF10 protects against PMLI by inhibiting ferroptosis via the Nrf2 signaling. Thus, FGF10 can be used as a novel ferroptosis suppressor and a potential treatment target in PMLI.